Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nicorandil on aortic stiffness in patients with acute coronary syndrome
KCT0001590Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nicorandil in acute coronary syndrome (ACS), sponsored by JW Pharmaceutical Corporation. Primary endpoint: Aortic stiffness. Started Aug 2012; status: completed.
02
Drugs
nicorandil
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on KCT0001590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001590.